Practice Points Developed for Treatment of Outpatient COVID-19
Molnupiravir and nirmatrelvir-ritonavir combination therapy should be considered for patients within five days of symptom onset
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.